Latest News
OBiO Technology Congratulates on The First Clinical Gene Editing Therapy to Treat An Overseas Patient in China by CorrectSequence Therapeutics
SHANGHAI, Aug. 5, 2024 /PRNewswire/ -- Recently, CorrectSequence Therapeutics Co., Ltd. (Correctseq) announced a significant milestone in their base editing therapy CS-101 for transfusion-dependent β-thalassemia. Utilizing their pioneering transformer Base Editor (tBE), Correctseq has successfull...
Yum China Reports Second Quarter Results
Record Second Quarter Revenue Led by Same-store Transaction Growth and New Unit Growth Improved OP Margin and Achieved Record Second Quarter Operating Profit Operating Profit Grew 4%, Core Operating Profit1 Grew 12%, Diluted EPS Grew 17% Record First Half Openings of 779 Net New Stores and Cash Ret...
Yum China Board Announces CFO Transition and Welcomes New Board Member
SHANGHAI, Aug. 5, 2024 /PRNewswire/ -- Yum China Holdings, Inc. (NYSE: YUMC and HKEX: 9987) (the "Company" or "Yum China") today announced that Andy Yeung, who has served as the Company's Chief Financial Officer sinceOctober 2019, intends to resign as the Company's Chief Financial Officer for per...
EarFun's New Premium Flagship Adaptive ANC Wireless Earbuds with Uncompromising Lossless Audio Featuring Auracast™
SANTA MONICA, Calif., Aug. 5, 2024 /PRNewswire/ -- The Air Pro 4 will be EarFun's next-gen flagship from their highly esteemed Air Pro series. Featuring a deep slate of upgrades and fresh tech, the sound and noise cancelation experience is expected to be an unparalleled value. In step with the s...
STRADVISION Accelerates Digital Transformation with New Data Pipeline Automation System
SEOUL, South Korea, Aug. 5, 2024 /PRNewswire/ -- STRADVISION
Chinese business delegation visits US, both sides agree to boost cooperation
BEIJING, Aug. 5, 2024 /PRNewswire/ -- This is a report from China.org.cn about a Chinese business delegation's visit to the U.S.:   A Chinese business delegation, led by Chairman Ren Hongbin of the China Council for the Promotion of International Trade (CCPIT), visited the Un...
Xiao-I Corporation Announces Plan to Implement ADS Ratio Change
SHANGHAI, Aug. 5, 2024 /PRNewswire/ -- Xiao-I Corporation ("Xiao-I" or the "Company") (NASDAQ: AIXI), a leading artificial intelligence company, today announced that it plans to change the ratio of its American Depositary Shares (the "ADSs") to its ordinary shares (the "ADS Ratio"), par valueUS$0...
META Pharmaceuticals announces FDA Grants Rare Pediatric Disease Designation to META-001-PH for the Treatment of Primary Hyperoxaluria
HONG KONG, Aug. 5, 2024 /PRNewswire/ -- META Pharmaceuticals Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation (RPDD) to its investigational new drug META-001-PH for the treatment of primary hyperoxaluria (PH).Primary hyperoxaluria is a...
Silicon Motion Launches the Best Performance/Watt PCIe Gen5 SSD Controller at FMS 2024
The Company Also Showcases SSD Solutions for Enterprise, PC, and Automotive AI Applications TAIPEI and MILPITAS, Calif., Aug. 5, 2024 /PRNewswire/ -- Silicon Motion Technology Corporation (NasdaqGS: SIMO) ("Silicon Motion"), a global leader in designing and marketing NAND flash controllers for s...
VSPO Chairman Dino Ying Named Vice President of Global Esports Federation
SHANGHAI, Aug. 5, 2024 /PRNewswire/ -- VSPO chairman and co-founder Dino Ying
has been named the vice president of the Global Esports Federation (GEF), the
world's leading esports federation.
Celebrating Speediance's 4th Anniversary: Revolutionizing the Fitness Industry
NEW YORK, Aug. 5, 2024 /PRNewswire/ -- Speediance
Antennova Announces CD73 Small Molecule Inhibitor Accepted for Mini Oral Presentation at ESMO Congress 2024
BOSTON, Aug. 5, 2024 /PRNewswire/ -- Antennova, a clinical-stage biotech company focused on oncology today announced that the orally administered CD73 small molecule inhibitor ATN-037(also known as ATG-037) has been accepted for Mini Oral presentation at the 2024 European Society of Medical Oncol...
QBIOTICS WELCOMES STEPHEN DOYLE AS CHIEF EXECUTIVE OFFICER
* Stephen Doyle has more than 24 years of experience in the global pharmaceutical industry, including leadership positions with companies such as Sanofi Aventis and Boehringer Ingelheim. He was most recently Chief Business Officer at Aslan Pharmaceuticals. * Mr Doyle brings extensive knowledg...
JinkoSolar Announces Cash Dividend
SHANGRAO, China, Aug. 5, 2024 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") (NYSE: JKS), one of the largest and most innovative solar module manufacturers in the world, today announced that its board of directors has declared a cash dividend ofUS$0.375 per ordinary ...
So-Young to Report Second Quarter 2024 Financial Results on August 23, 2024
BEIJING, Aug. 5, 2024 /PRNewswire/ -- So-Young International Inc. (NASDAQ: SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced that it will report its financ...
Viomi Technology Co., Ltd to Report First Half 2024 Financial Results on Monday, August 26, 2024
Earnings Call Scheduled for 8:00 A.M. ET on August 26, 2024 GUANGZHOU, China, Aug. 5, 2024 /PRNewswire/ -- Viomi Technology Co., Ltd ("Viomi" or the "Company") (NASDAQ: VIOT),a leading IoT @ Home technology company inChina, today announced that it will report its unaudited financial results for ...
NetEase to Report Second Quarter 2024 Financial Results on August 22
HANGZHOU, China, Aug. 5, 2024 /PRNewswire/ -- NetEase, Inc. (NASDAQ: NTES and HKEX: 9999, "NetEase" or the "Company"), a leading internet and game services provider, today announced that it will report financial results for the 2024 second quarter onThursday, August 22, 2024, before the open of t...
Formosa Pharmaceuticals Announces Licensing Agreement with Apotex Inc., for Commercialization of Clobetasol Propionate Ophthalmic Suspension for Ocular Surgery Relief and Recovery
TAIPEI, Aug. 5, 2024 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals (" Formosa", 6838.TWO) announced today that the company has entered into an exclusive licensing agreement with Apotex Inc. ("Apotex"), for exclusive rights inCanada to the commercialization of clobetasol propionate ophthalmi...
Youdao to Report Second Quarter 2024 Financial Results on August 22
HANGZHOU, China, Aug. 5, 2024 /PRNewswire/ -- Youdao, Inc. ("Youdao" or the "Company") (NYSE: DAO), an intelligent learning company with industry-leading technology inChina, today announced that it will report its second quarter 2024 financial results onThursday, August 22, 2024, before the open ...
Retracing the footsteps of Dr Norman Bethune
BEIJING, Aug. 4, 2024 /PRNewswire/ -- A report from People's Daily
Week's Top Stories
Most Reposted
vVardis Raises $175 Million Ahead of NYSE IPO: NYSE Content Update
[Picked up by 1187 media titles]
2026-11-13 22:11The NYSE Welcomes vVARDIS as a Publicly Listed Company
[Picked up by 1173 media titles]
2026-11-14 13:23Cision Introduces AI-Powered Cision Intelligence to Help Brands See More and Act with Confidence
[Picked up by 1172 media titles]
2026-11-12 23:00Cyient, 3-GIS Partner to Help Telecom and Utility Operators Turn Network Data into Operational Control
[Picked up by 1155 media titles]
2026-11-11 22:00Kraft Heinz Casts Spotlight on its NYSE Listing: NYSE Content Update
[Picked up by 1088 media titles]
2026-11-12 21:55